comprehensive -WSS

comprehensive

author：fashion 2025-09-06 02:04:48 - browse：162

green electrocardiogram scan. -- health tech coverage from STAT — Adobe

As Bristol Myers Squibb works to build its treatment for a heart condition that can cause difficulty breathing into a blockbuster drug, it’s propped up an algorithm designed to help find more people who are affected.

The algorithm, which is part of software developed by Viz.ai, earlier this month received clearance from the Food and Drug Administration. The tool, called Viz HCM, looks at 12-lead electrocardiograms collected during routine care and flags suspected cases of hypertrophic cardiomyopathy, or HCM, for further evaluation. As part of a multi-year agreement between the companies, BMS — whose drug, Camzyos, is used to treat HCM — provided funding and scientific input for the development of the algorithm.

“BMS has a vested interest in finding more patients with HCM,” said Matthew Martinez, a cardiologist who leads Viz.ai’s HCM medical advisory board. “Why? Because they’re so philanthropic? No, they want to sell more drugs. They want to help more people by identifying more people.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The high cost of giving birth even with insurance
Next article： Cell therapy fails to slow type 1 diabetes, but safety is established

entertainment

hotspot

WSS

'The View' co

Q&A: Jennifer Adair on making gene therapy available globally

Medical bills so high, Medicare adding extra digits to claim forms

Medical bills so high, Medicare adding extra digits to claim forms

Close Medicare's dangerous gaps in addiction treatment coverage

Why Marc Tessier

knowledge

comprehensive

Wikipedia

Medicare details structure of new drug price negotiation program

EMA weighs against approval for Mirati's lung cancer drug

ChatGPT in medicine: STAT answers readers' burning questions

How Brent Saunders' Allergan experiment failed

How one medical school became remarkably diverse

Study: Misdiagnosis causes 800,000 deaths, serious disabilities a year in U.S.

Continuity nursing helped my family in our darkest PICU moments

Why the advice to take all your antibiotics may be wrong

Jerome Adams on the need for new antivirals for Covid

'The View' co

leisure time

Diversity in clinical trials starts with building trust, experts say

Pfizer's RSV vaccine recommended for approval in Europe

Orangutan used medicinal plant to treat wound, first time ever seen

A new deal aims to ramp up use of AI in rehab care decisions

Family of Gilgo Beach murder suspect releases statement: 'Devastating time'

MassMutual is introducing free genetic testing for members

entertainment

hotspot

hotspot

focus